LCAT
Phosphatidylcholine-sterol acyltransferase
Also known as: LCAT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04180
- Gene
- LCAT
- Ensembl
- ENSG00000213398
- Chromosome
- 16
- Canonical length
- 440 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes the extracellular cholesterol esterifying enzyme, lecithin-cholesterol acyltransferase. The esterification of cholesterol is required for cholesterol transport. Mutations in this gene have been found to cause fish-eye disease as well as LCAT deficiency. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
440 residues, UniProt reviewed canonical sequence.
>P04180|LCAT
1 MGPPGSPWQW VTLLLGLLLP PAAPFWLLNV LFPPHTTPKA ELSNHTRPVI LVPGCLGNQL
61 EAKLDKPDVV NWMCYRKTED FFTIWLDLNM FLPLGVDCWI DNTRVVYNRS SGLVSNAPGV
121 QIRVPGFGKT YSVEYLDSSK LAGYLHTLVQ NLVNNGYVRD ETVRAAPYDW RLEPGQQEEY
181 YRKLAGLVEE MHAAYGKPVF LIGHSLGCLH LLYFLLRQPQ AWKDRFIDGF ISLGAPWGGS
241 IKPMLVLASG DNQGIPIMSS IKLKEEQRIT TTSPWMFPSR MAWPEDHVFI STPSFNYTGR
301 DFQRFFADLH FEEGWYMWLQ SRDLLAGLPA PGVEVYCLYG VGLPTPRTYI YDHGFPYTDP
361 VGVLYEDGDD TVATRSTELC GLWQGRQPQP VHLLPLHGIQ HLNMVFSNLT LEHINAILLG
421 AYRQGPPASP TASPEPPPPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against LCAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 276 nTPM
Expression across tissuesHPA
Tissue
- liver: 276 nTPM
- cerebellum: 68 nTPM
- choroid plexus: 43 nTPM
- thyroid gland: 42 nTPM
- heart muscle: 41 nTPM
- prostate: 39 nTPM
Single-cell type
- bergmann glia: 306 nCPM
- hepatocytes: 241 nCPM
- choroid plexus epithelial cells: 56 nCPM
- astrocytes: 42 nCPM
- ependymal cells: 21 nCPM
- pituicytes/fscs: 18 nCPM
Immune cell
- eosinophil: 1.9 nTPM
- neutrophil: 1 nTPM
- basophil: 0.9 nTPM
- naive B-cell: 0.6 nTPM
- MAIT T-cell: 0.5 nTPM
- classical monocyte: 0.4 nTPM
Brain region
- cerebellum: 82 nTPM
- medulla oblongata: 51 nTPM
- choroid plexus: 42 nTPM
- thalamus: 33 nTPM
- cerebral cortex: 32 nTPM
- midbrain: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LCAT.
Disease | AllUniProt
Conditions LCAT is implicated in, by any mechanism.
- Lecithin-cholesterol acyltransferase deficiency (LCATD) MIM:245900
- Fish-eye disease (FED) MIM:136120
Disease | GeneticClinVar
39 pathogenic / likely-pathogenic of 353 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Fish-eye disease
- Norum disease
- LCAT deficiency
- Cardiovascular phenotype
- LCAT-related disorder
ReferencesPubMed · IEDB
Publications for LCAT from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin-Cholesterol Acyltransferase Autoantibody.
2023 · J Atheroscler Thromb · RCR 0.7 · 4 citations - [Glomerulopathy associated with lecithin-cholesterol-acyltransferase deficiency: A case report and literature review].
2019 · Ann Pathol · RCR 0.1 · 2 citations - A Rare Case of Autoimmune-Mediated Lecithin:Cholesterol Acyltransferase Insufficiency Manifesting as the Acute Onset of Extremely Hypo-High-Density Lipoprotein-Cholesterolemia and Spontaneous Improvement: A Case Report with a Review of the Literature.
2025 · J Atheroscler Thromb · 3 citations - Short-Term Treatment for Immune-Mediated Acquired Lecithin-Cholesterol Acyltransferase Deficiency Restores the High-Density Lipoprotein Function: A Case Report.
2025 · J Atheroscler Thromb · 1 citations - Severe HDL-C Deficiency Caused by Acquired LCAT Deficiency: A Case Report with Lipidomic Profiling and Anti-LCAT Autoantibody Detection.
2026 · Intern Med
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aflatoxin metabolic process
- cholesterol homeostasis
- cholesterol metabolic process
- cholesterol transport
- high-density lipoprotein particle remodeling
- lipid metabolic process
- lipoprotein biosynthetic process
- phosphatidylcholine biosynthetic process
- phosphatidylcholine metabolic process
- phospholipid metabolic process
- regulation of high-density lipoprotein particle assembly
- response to copper ion
- response to glucocorticoid
- reverse cholesterol transport
- very-low-density lipoprotein particle remodeling
Molecular functions
- 1-alkyl-2-acetylglycerophosphocholine esterase activity
- apolipoprotein A-I binding
- phospholipase A2 activity
- platelet-activating factor acetyltransferase activity
- sterol ester esterase activity
- phosphatidylcholine-sterol O-acyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LCAT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LCAT as an antibody target. Whether an autoantibody or antibody against LCAT could matter depends on whether native LCAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LCAT is annotated as secreted, so native LCAT circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LCAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...